4-(6-Bromopyrazin-2-yl)morpholine

Catalog No. :
ACPFKS061
CAS No. :
848841-62-3
Molecular Formula :
C8H10BrN3O
Molecular Weight :
244.09

IUPAC Name:4-(6-bromopyrazin-2-yl)morpholine

4-(6-Bromopyrazin-2-yl)morpholine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$62.00Login to see priceIn stockInquiry
5g98%$199.00Login to see priceIn stockInquiry
25g98%$905.00Login to see priceIn stockInquiry
100g98%$3258.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(6-Bromopyrazin-2-yl)morpholine
IUPAC Name4-(6-bromopyrazin-2-yl)morpholine
MDL No.MFCD09607709
Molecular FormulaC8H10BrN3O
Molecular Weight244.09
SMILESBrC1=CN=CC(=N1)N2CCOCC2
InChI KeyOVLIISDBFJFQQH-UHFFFAOYSA-N
Synonym4-(6-Bromopyrazin-2-yl)morpholine | 848841-62-3 | 2-bromo-6-morpholinopyrazine | SCHEMBL5524143 | DTXSID00671673 | OVLIISDBFJFQQH-UHFFFAOYSA-N | MFCD09607709 | 4-(6-bromo-pyrazin-2-yl)-morpholine | AKOS015835788 | GS-4351 | CS-0186876 | FT-0645637
CAS No.848841-62-3
PubChem CID45787515

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACPFKS061 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHPOW357 route compound structure diagram
    ACHPOW35723229-25-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPFKS061 route product structure diagram
    ACPFKS061848841-62-3 In Stock
Inquiry

2. ACPFKS061 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAGNO847 route compound structure diagram
    ACAGNO847916791-07-6 In Stock
  4. Then
  5. ACPFKS061 route product structure diagram
    ACPFKS061848841-62-3 In Stock
Inquiry

Comments (0)